Concepedia

Eugenie S. Kleinerman

ES

159

Publications

9.4K

Citations

53

H-Index

1974

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

National Institutes of Health

Baylor College of Medicine

Memorial Sloan Kettering Cancer Center

Eugenie S. Kleinerman is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, immunology, and cell biology.

ORCID

Top concepts

Publications per year

1974–2024

159

Publications

159

Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

Paul A. Meyers, Cindy L. Schwartz, Mark Krailo et al. · Journal of Clinical Oncology · 2008 · 734 citations · Full text

Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Dose Methotrexate

Paul A. Meyers, Cindy L. Schwartz, Mark Krailo et al. · Journal of Clinical Oncology · 2005 · 711 citations · Full text

Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma

Alexander J. Chou, Eugenie S. Kleinerman, Mark Krailo et al. · Cancer · 2009 · 237 citations · Full text

Toward a Drug Development Path That Targets Metastatic Progression in Osteosarcoma

Chand Khanna, Timothy M. Fan, Richard Görlick et al. · Clinical Cancer Research · 2014 · 198 citations · Full text

Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary.

Richard Görlick, Peter M. Anderson, Irene L. Andrulis et al. · PubMed · 2003 · 198 citations

, , +17

Rows per page

1–5 of 159